GW Pharmaceuticals Plc (GWP) - Financial and Strategic SWOT Analysis Review

Date: June 21, 2016
Pages: 48
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G8DC1FEF4EFEN
Leaflet:

Download PDF Leaflet

GW Pharmaceuticals Plc (GWP) - Financial and Strategic SWOT Analysis Review
GW Pharmaceuticals Plc (GWP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s product Sativex is a plant-derived cannabinoid prescription drug, for the treatment of spasticity due to multiple sclerosis and Epidiolex is an orphan drug for the treatment of Dravet syndrome and Lennox-Gastaut syndrome. It sells and distributes the product through strategic collaborations with many pharmaceutical companies. GW Pharmaceuticals is also developing other product pipeline which is focused on treatment of diabetes, schizophrenia, cancer pain, cerebral palsy, autism among others. The company along with its subsidiaries operates in the US, England and Wales. GW Pharmaceuticals is headquartered in Salisbury, Wiltshire, the UK.

GW Pharmaceuticals Plc Key Recent Developments

May 05, 2016: GW Pharmaceuticals Reports Second Quarter and Half-Year 2016 Financial Results and Operational Progress
Feb 10, 2016: GW Pharmaceuticals Reports First Quarter 2016 Financial Results and Operational Progress
Jan 05, 2016: Cannabis-based drug reduces seizures in children with treatment-resistant epilepsy
Aug 06, 2015: GW Pharmaceuticals Reports Third Quarter 2015 Financial Results and Operational Progress
Jul 16, 2015: GW Pharmaceuticals announces Appointment Of Director

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

GW Pharmaceuticals Plc - Key Facts
GW Pharmaceuticals Plc - Key Employees
GW Pharmaceuticals Plc - Key Employee Biographies
GW Pharmaceuticals Plc - Major Products and Services
GW Pharmaceuticals Plc - Pharmaceutical Pipeline Products Data
GW Pharmaceuticals Plc, Pipeline Products by Therapy Area
GW Pharmaceuticals Plc, Pipeline Products by Development Phase
GW Pharmaceuticals Plc - History
GW Pharmaceuticals Plc - Company Statement
GW Pharmaceuticals Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

GW Pharmaceuticals Plc - Business Description
GW Pharmaceuticals Plc - Corporate Strategy
GW Pharmaceuticals Plc - SWOT Analysis
SWOT Analysis - Overview
GW Pharmaceuticals Plc - Strengths
Strength - Focused Research and Development
Strength - Dominant Position
GW Pharmaceuticals Plc - Weaknesses
Weakness - Misleading Information
GW Pharmaceuticals Plc - Opportunities
Opportunity - Orphan Drug Designation - Epidiolex
Opportunity - Agreements
GW Pharmaceuticals Plc - Threats
Threat - Competitive Landscape
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
GW Pharmaceuticals Plc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
GW Pharmaceuticals Plc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 05, 2016: GW Pharmaceuticals Reports Second Quarter and Half-Year 2016 Financial Results and Operational Progress
Feb 10, 2016: GW Pharmaceuticals Reports First Quarter 2016 Financial Results and Operational Progress
Jan 05, 2016: Cannabis-based drug reduces seizures in children with treatment-resistant epilepsy
Aug 06, 2015: GW Pharmaceuticals Reports Third Quarter 2015 Financial Results and Operational Progress
Jul 16, 2015: GW Pharmaceuticals announces Appointment Of Director
May 19, 2015: GW Appoints Senior Industry Executive to President, North America and Relocates CEO to the U.S.
May 11, 2015: GW Pharmaceuticals Reports Second Quarter 2015 Financial Results and Operational Progress
Feb 04, 2015: GW Pharmaceuticals Reports First Quarter 2015 Financial Results and Operational Progress

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

GW Pharmaceuticals Plc, Key Facts
GW Pharmaceuticals Plc, Key Employees
GW Pharmaceuticals Plc, Key Employee Biographies
GW Pharmaceuticals Plc, Major Products and Services
GW Pharmaceuticals Plc, Number of Pipeline Products by Therapy Area
GW Pharmaceuticals Plc, Number of Pipeline Products by Development Stage
GW Pharmaceuticals Plc, Pipeline Products By Therapy Area and Development Phase
GW Pharmaceuticals Plc, History
GW Pharmaceuticals Plc, Other Locations
GW Pharmaceuticals Plc, Subsidiaries
GW Pharmaceuticals Plc, Key Competitors
GW Pharmaceuticals Plc, Ratios based on current share price
GW Pharmaceuticals Plc, Annual Ratios
GW Pharmaceuticals Plc, Interim Ratios
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
GW Pharmaceuticals Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

GW Pharmaceuticals Plc, Pipeline Products by Therapy Area
GW Pharmaceuticals Plc, Pipeline Products by Development Phase
GW Pharmaceuticals Plc, Performance Chart (2011 - 2015)
GW Pharmaceuticals Plc, Ratio Charts
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
GW Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Tyrian Diagnostics Limited
Sinclair Pharma Plc
Oxford BioMedica Plc
Napp Pharmaceuticals Limited
Immupharma Plc
Evotec AG
Echo Pharmaceuticals B.V.
Biogen, Inc.
AstraZeneca Plc
Skip to top


Ask Your Question

GW Pharmaceuticals Plc (GWP) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: